SINC increases extra 100 tons/month of its medical Nylon capacity, in supporting for the logistics of Chinese Covid Vaccine Production:

Melbourne, Australia, Feb 7^th, 2022 - Sincerity Applied Materials Holdings Corp (OTC Pink: SINC), through its prospective subsidiary SIMCOR, has scheduled an extra 100 tons/month medical grade Nylon capacity, in support for the logistics of the local Chinese Covid Vaccine Production.

SINC medical grade engineering plastics has been widely used in medical industry during this pandemic; they can be found in air purifiers, face masks, vaccine productions, and covid testing kits etc.

SINC has moved its R&D centre to China Israel Innovation Park in Changzhou, Jiangsu, China, which are filled with industry 4.0 factories in EV, 5G, medical and automotive industries.

About Sincerity Applied Materials Holding Corp

Sincerity Applied Materials delivers high performance environmental polymer and solutions, to help customers reducing product wastage, improve logistics efficiency, and reduce their carbon footprint. The Company, though its China partner, has been developing its exceptional material technology through partnerships with leading Chinese research institutions and facilities. Today, Sincerity's products are widely used in the automotive, packaging, building & construction and engineering industries.

Forward-Looking Statements

This press release contains certain forward-looking statements. Investors are cautioned that certain statements in this release are "forward-looking statements" and involve both known and unknown risks, uncertainties and other factors. Such uncertainties include, among others, certain risks associated with the operation of the company described above. The Company's actual results could differ materially from expected results.

Contact Information:

Investor Relations:

CORE IR
+1 516 222 2560

IR@sincerityplastics.com